Bioactivity | GPR40 agonist 6 (Compound 7a) is a potent and selective free fatty acid receptor 1 (FFAR1 or GPR40) agonist with an EC50 of 0.058 μM[1]. | ||||||||||||
Target | EC50: 0.058 μM (GPR40) | ||||||||||||
Invitro | GPR40 agonist 6 (Compound 7a) shows a very favorable ADME profile, and shows no significant inhibition of the principal cytochrome P450 isoforms (1A2, 2C9, 2C19, 2D6 and 3A4) at 5 µM[1].ADME profile for GPR40 agonist 6 (Compound 7a)[1] | ||||||||||||
Name | GPR40 agonist 6 | ||||||||||||
CAS | 1798751-25-3 | ||||||||||||
Formula | C20H19NO4 | ||||||||||||
Molar Mass | 337.37 | ||||||||||||
Appearance | Solid | ||||||||||||
Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
Storage |
|
||||||||||||
Reference | [1]. Zahanich I, et al. Phenoxymethyl 1,3-oxazoles and 1,2,4-oxadiazoles as potent and selective agonists of free fatty acid receptor 1 (GPR40). Bioorg Med Chem Lett. 2015 Aug 15;25(16):3105-11. |